About this trial

This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Newly diagnosed bladder cancer on cystoscopy

Planned TURBT or cystectomy within 6 weeks

Eligible for both CT and MRI within 6 weeks

Disqualifiers

Contraindications to MRI or iodinated contrast media

Prior treatment for bladder cancer

Pregnancy

Non-malignant bladder lesions

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 1 trial group

Locations

1
Oslo University Hospital Oslo Norway

Sponsors and collaborators

Oslo University Hospital

Lead sponsor